Table 2 Overall prescription prevalence in the endometriosis and non-endometriosis cohorts
From: Investigating racial disparities in drug prescriptions for patients with endometriosis
Endometriosis cohort | Non-endometriosis cohort | |||
|---|---|---|---|---|
Prevalence difference (SE) (%) | Adjusted p-value | Prevalence difference (SE) (%) | Adjusted p-value | |
Anti-infectives and antiseptics, excl. combinations with corticosteroids | −3.75 (1.06) | 0.0059 | −6.37 (0.052) | 0 |
Anti-inflammatory and antirheumatic products, non-steroids | 1.05 (0.52) | 0.60 | 1.18 (0.058) | 1.98E−90 |
Antidepressants | 21.89 (1.01) | 9.39E−104 | 22.90 (0.053) | 0 |
Antiemetics and antinauseants | 4.38 (1.74) | 5.49E−08 | 7.03 (0.058) | 0 |
Antiepileptics | 21.95 (1.11) | 3.48E−85 | 12.93 (0.044) | 0 |
Antifibrinolytics | −0.97 (0.32) | 0.040 | 0.0079 (0.0061) | 2.77322788 |
Antihistamines for systemic use | 4.82 (0.81) | 3.79E−08 | 3.92 (0.059) | 0 |
Anxiolytics | 23.23 (1.06) | 1.14E−105 | 15.65 (0.050) | 0 |
Belladonna and derivatives, plain | 5.30 (0.93) | 1.50E−07 | 2.25 (0.025) | 0 |
Corticosteroids for systemic use, plain | 8.34 (0.77) | 1.80E−26 | 12.03 (0.058) | 0 |
Cough suppressants, excl. combinations with expectorants | 9.39 (0.97) | 4.62E−21 | 5.99 (0.032) | 0 |
Drugs for constipation | −3.67 (1.14) | 0.018 | −1.04 (0.045) | 8.26E−119 |
Drugs for functional gastrointestinal disorders | 8.78 (1.04) | 5.04E−16 | 2.98 (0.029) | 0 |
Drugs for peptic ulcer and gastro-esophageal reflux disease (GERD) | 8.34 (1.09) | 3.06E−13 | 7.16 (0.052) | 0 |
Estrogens | 10.91 (0.97) | 2.40E−28 | 1.83 (0.024) | 0 |
Hormonal contraceptives for systemic use | −0.76 (1.09) | 6.80 | −1.98 (0.058) | 1.04E−252 |
Hormones and related agents | −9.96 (1.14) | 2.80E−17 | −8.92 (0.049) | 0 |
Hypnotics and sedatives | 8.76 (1.05) | 7.98E−16 | 7.12 (0.045) | 0 |
Iron preparations | −7.29 (0.83) | 1.84E−17 | −4.45 (0.034) | 0 |
Opioids | 1.07 (0.39) | 0.089 | 4.93 (0.058) | 0 |
Other analgesics and antipyretics | 6.55 (0.87) | 8.25E−13 | 7.47 (0.057) | 0 |
Other diagnostic agents | 2.44 (0.78) | 0.027 | 0.67 (0.024) | 3.35E−173 |
Other systemic drugs for obstructive airway diseases | 3.28 (0.81) | 0.00076 | 1.57 (0.028) | 0 |
Progestogens | −6.50 (1.14) | 1.61E−07 | −7.87 (0.052) | 0 |
Quinolone antibacterials | 7.92 (1.09) | 4.43E−12 | 6.41 (0.049) | 0 |
Selective calcium channel blockers with direct cardiac effects | 0.47 (0.46) | 4.29 | 0.14 (0.012) | 5.63E−34 |
Thyroid preparations | 8.47 (0.64) | 2.62E−39 | 4.44 (0.022) | 0 |
Urologicals | 9.05 (0.93) | 4.89E−21 | 2.9 (0.026) | 0 |
